Correlation Between Veracyte and TNF Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both Veracyte and TNF Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and TNF Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Veracyte and TNF Pharmaceuticals,, you can compare the effects of market volatilities on Veracyte and TNF Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of TNF Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and TNF Pharmaceuticals,.

Diversification Opportunities for Veracyte and TNF Pharmaceuticals,

-0.7

Correlation Coefficient

Veracyte  TNF Pharmaceuticals,

Excellent diversification

The 3 months correlation between Veracyte and TNF is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and TNF Pharmaceuticals, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TNF Pharmaceuticals, and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with TNF Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TNF Pharmaceuticals, has no effect on the direction of Veracyte i.e., Veracyte and TNF Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Veracyte and TNF Pharmaceuticals,

Given the investment horizon of 90 days Veracyte is expected to generate 31.78 times less return on investment than TNF Pharmaceuticals,. But when comparing it to its historical volatility, Veracyte is 3.5 times less risky than TNF Pharmaceuticals,. It trades about 0.0 of its potential returns per unit of risk. TNF Pharmaceuticals, is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  140.00  in TNF Pharmaceuticals, on September 24, 2024 and sell it today you would lose (4.00) from holding TNF Pharmaceuticals, or give up 2.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Veracyte  vs.  TNF Pharmaceuticals,

Veracyte

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.

TNF Pharmaceuticals,

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in TNF Pharmaceuticals, are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady technical and fundamental indicators, TNF Pharmaceuticals, sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Veracyte and TNF Pharmaceuticals,

The main advantage of trading using opposite Veracyte and TNF Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, TNF Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TNF Pharmaceuticals, will offset losses from the drop in TNF Pharmaceuticals,'s long position.

The idea behind Veracyte and TNF Pharmaceuticals, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.